Author

María González-Bermejo

Hospital Nacional de ParapléjicosORCID 0009-0008-1585-1138Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Alberto ParadelaiD· 1 shared Alberto Pérez‐SamartíniD· 1 shared Aldo BorrotoiD· 1 shared Alejandra M. Arroyo· 1 shared Balbino AlarcóniD· 1 shared Beatriz Sancho-González· 1 shared Carlos MatuteiD· 1 shared Chao ZhengiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alberto ParadelaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsbioRxivPreprintFeb 19, 2026

A single-cell atlas linking intratumoral states to therapeutic vulnerabilities across cancers

María González-Bermejo, Laura Serrano-Ron, Santiago García‐Martín…·Fátima Al‐Shahrour

The paper presents a pan-cancer single-cell atlas linking intratumoral states to therapeutic vulnerabilities by integrating transcriptomics, copy-number alterations, and drug-response predictions across 34 tumor types.

DOI 10.64898/2026.02.18.706316

humanscRNA-seq

𝕏 PostBluesky

NeurosciencebioRxivPreprintAug 23, 2024

TAF1-dependent transcriptional dysregulation underlies multiple sclerosis

Claudia Rodríguez-López, Ivó H. Hernández, José Terrón-Bautista…·José J. Lucas

This study identifies TAF1-dependent transcriptional dysregulation as a mechanism underlying multiple sclerosis progression and presents an in vivo model for therapeutic development.

DOI 10.1101/2024.08.23.609325

humanbulk RNA-seq

𝕏 PostBluesky